Baseline interleukin-10, CD163, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12-week follow-up study,Journal of Periodontology

当前位置： X-MOL 学术 › J. Periodontol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Baseline interleukin-10, CD163, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12-week follow-up study
Journal of Periodontology ( IF 4.2 ) Pub Date : 2022-07-12 , DOI: 10.1002/jper.22-0242
Mustafa Yilmaz _{1,

2} , Esra Demir ₃ , Mervi Gürsoy _{1,

4} , Erhan Firatli ₅ , Ulvi Kahraman Gürsoy ₁

Affiliation

The aim of this study was to examine the relationship between healing response after non-surgical periodontal treatment and baseline gingival tissue levels of M2 macrophage activation-related proteins CD163, interleukin (IL)-10, interferon (IFN)-γ, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and the CD163/TWEAK ratio.

中文翻译：

基线白细胞介素 10、CD163 和肿瘤坏死因子样细胞凋亡弱诱导物 (TWEAK) 牙龈组织水平与临床牙周治疗结果的关系：一项为期 12 周的随访研究

本研究的目的是检查非手术牙周治疗后的愈合反应与 M2 巨噬细胞激活相关蛋白 CD163、白细胞介素 (IL)-10、干扰素 (IFN)-γ 和肿瘤坏死的基线牙龈组织水平之间的关系细胞凋亡弱诱导因子 (TWEAK) 和 CD163/TWEAK 比率。

更新日期：2022-07-12

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11